Profile data is unavailable for this security.
About the company
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
- Revenue in USD (TTM)9.47m
- Net income in USD-2.30m
- Incorporated2017
- Employees30.00
- LocationBioNexus Gene Lab CorpTower B, Vertical Business Suite, 10-2,KUALA LUMPUR 59200MalaysiaMYS
- Phone+0 160 122126512
- Websitehttps://www.bionexusgenelab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannabis Bioscience Internatnl Hlgs Inc | 148.34k | -555.16k | 4.65m | 2.00 | -- | -- | -- | 31.35 | -0.00006 | -0.00006 | 0.00001 | -0.0001 | 4.55 | -- | 11.35 | 74,170.00 | -1,702.42 | -652.66 | -- | -- | 73.11 | 87.76 | -374.25 | -177.59 | -- | -4.30 | -- | -- | 21.77 | 0.8662 | 15.74 | -- | -- | -- |
| Genprex Inc | 0.00 | -17.05m | 4.68m | 15.00 | -- | 2.64 | -- | -- | -52.85 | -52.85 | 0.00 | 0.7646 | 0.00 | -- | -- | 0.00 | -448.99 | -100.44 | -1,253.41 | -109.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 30.69 | -- | -- | -- |
| Decoy Therapeutics Inc | 0.00 | -5.00m | 4.72m | 2.00 | -- | 0.1643 | -- | -- | -39.19 | -39.19 | 0.00 | 4.50 | 0.00 | -- | -- | 0.00 | -100.54 | -73.17 | -139.55 | -84.56 | -- | -- | -- | -987.44 | -- | -- | 0.00 | -- | -- | -- | 55.55 | -- | -- | -- |
| Bio Green Med Solution Inc | 81.00k | -6.97m | 4.81m | 12.00 | -- | 0.4835 | -- | 59.32 | -80.13 | -80.13 | 0.0775 | 2.03 | 0.012 | -- | 0.0821 | -- | -80.35 | -65.34 | -175.85 | -83.85 | 20.99 | -- | -6,714.82 | -17,774.73 | 5.07 | -241.39 | 0.00 | -- | -89.76 | -- | 50.73 | -- | -- | -- |
| Bioxytran Inc | 0.00 | -2.11m | 4.81m | 2.00 | -- | -- | -- | -- | -0.0235 | -0.0235 | 0.00 | -0.0326 | 0.00 | -- | -- | -- | -1,340.44 | -1,468.56 | -- | -- | -- | -- | -- | -- | -- | -1.99 | -- | -- | -- | -- | 47.08 | -- | -- | -- |
| Cyclerion Therapeutics Inc | 2.86m | -2.20m | 4.91m | 1.00 | -- | 0.4843 | -- | 1.72 | -0.7587 | -0.7587 | 1.00 | 2.58 | 0.2957 | -- | 39.65 | 2,855,000.00 | -22.77 | -53.70 | -24.80 | -63.57 | -- | -- | -77.02 | -1,913.83 | -- | -- | 0.00 | -- | -- | -15.00 | 75.72 | -- | -- | -- |
| Aspire Biopharma Holdings Inc | 1.94k | -28.70m | 4.95m | -- | -- | -- | -- | 2,551.26 | -65.96 | -65.96 | 0.0022 | -9.26 | 0.0004 | -- | -- | -- | -633.21 | -- | -- | -- | 45.36 | -- | -1,479,598.00 | -- | 0.1708 | -6.20 | -- | -- | -- | -- | -380.85 | -- | -- | -- |
| Weed Inc | 0.00 | -755.25k | 4.96m | 2.00 | -- | -- | -- | -- | -0.0058 | -0.0058 | 0.00 | -0.0038 | 0.00 | -- | -- | 0.00 | -133.78 | -117.17 | -- | -371.94 | -- | -- | -- | -- | -- | -22.55 | -- | -- | -- | -- | -1,518.25 | -- | -- | -- |
| Silexion Therapeutics Corp | 0.00 | -9.25m | 4.97m | 11.00 | -- | 0.7125 | -- | -- | -25.21 | -25.21 | 0.00 | 2.23 | 0.00 | -- | -- | 0.00 | -125.80 | -- | -221.96 | -- | -- | -- | -- | -- | -- | -84.50 | 0.1808 | -- | -- | -- | -223.39 | -- | -- | -- |
| Xenetic Biosciences Inc | 2.86m | -3.16m | 4.98m | 2.00 | -- | 0.8478 | -- | 1.74 | -2.05 | -2.05 | 1.85 | 2.57 | 0.436 | -- | -- | 1,429,470.00 | -48.14 | -42.99 | -57.42 | -46.44 | -- | -- | -110.40 | -373.71 | -- | -- | 0.00 | -- | -1.56 | 171.11 | 4.22 | -- | -- | -- |
| Acurx Pharmaceuticals Inc | 0.00 | -9.17m | 5.02m | 4.00 | -- | 0.9751 | -- | -- | -8.54 | -8.54 | 0.00 | 2.02 | 0.00 | -- | -- | 0.00 | -151.72 | -158.12 | -291.07 | -208.61 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.26 | -- | -- | -- |
| Processa Pharmaceuticals Inc | 0.00 | -12.93m | 5.03m | 10.00 | -- | 0.8047 | -- | -- | -35.00 | -35.00 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -206.50 | -104.23 | -270.68 | -112.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.55 | -- | -- | -- |
| BioNexus Gene Lab Corp | 9.47m | -2.30m | 5.06m | 30.00 | -- | 0.5641 | -- | 0.5345 | -1.28 | -1.28 | 5.27 | 3.79 | 1.02 | 6.73 | 6.42 | -- | -24.68 | -6.00 | -27.80 | -7.75 | 14.77 | 14.31 | -24.27 | -4.98 | 6.81 | -1,354.05 | 0.00 | -- | -2.66 | 137.09 | 39.20 | -- | 77.67 | -- |
| VivoSim Labs Inc | 140.00k | -1.98m | 5.22m | 5.00 | -- | 0.7383 | -- | 37.26 | -0.1898 | -0.1898 | 0.068 | 2.71 | 0.017 | -- | 4.59 | 10,769.23 | -24.12 | -51.63 | -34.26 | -56.47 | 98.57 | -- | -1,416.43 | -2,952.99 | -- | -- | 0.00 | -- | 32.11 | -42.01 | 83.04 | -- | -- | -- |
| Bullfrog AI Holdings Inc | 116.67k | -6.76m | 5.25m | 9.00 | -- | 2.47 | -- | 45.01 | -0.6936 | -0.6936 | 0.0119 | 0.1866 | 0.0319 | -- | -- | 12,963.33 | -184.34 | -- | -233.50 | -- | 18.76 | -- | -5,770.66 | -- | -- | -- | 0.0278 | -- | -100.00 | -- | -31.42 | -- | -- | -- |
| MetaVia Inc | 0.00 | -16.22m | 5.26m | 9.00 | -- | 0.5703 | -- | -- | -13.88 | -13.88 | 0.00 | 2.88 | 0.00 | -- | -- | 0.00 | -87.87 | -99.54 | -167.49 | -140.07 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -121.27 | -- | -48.18 | -- |
Data as of Feb 17 2026. Currency figures normalised to BioNexus Gene Lab Corp's reporting currency: US Dollar USD
1.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| DRW Securities LLCas of 31 Dec 2025 | 47.83k | 1.98% |
| UBS Securities LLCas of 31 Dec 2025 | 0.00 | 0.00% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
